Clinical Trials on Locally Advanced Triple-Negative Breast Carcinoma in Netherlands
Total 58 results
-
The Netherlands Cancer InstituteCompletedLocally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast CarcinomaNetherlands
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBreast CancerNetherlands
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingMetastatic Breast CancerNetherlands
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
SanofiTerminatedTriple Negative Breast CancerSpain, Belgium, Italy, Czechia, Netherlands
-
SanofiCompletedBreast Cancer, MetastaticAustralia, Belgium, France, Italy, Netherlands, Spain
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruiting
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
AbbVieNSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...CompletedTriple Negative Breast CancerUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
GlaxoSmithKlineActive, not recruitingNeoplasms, BreastUnited States, Argentina, France, Netherlands, Finland, Spain, Israel, Poland, Romania, Mexico, Canada, Belgium, Germany, Hungary, Portugal, United Kingdom, Ireland, Australia, Italy, Brazil, Japan, Austria, Russian Federation, South... and more
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
Cantargia ABActive, not recruitingColorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaAustria, Denmark, Germany, Belgium, Spain, Latvia, Netherlands, Lithuania, Estonia, Sweden, Norway
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell CarcinomaUnited States, Spain, Taiwan, Germany, Netherlands, United Kingdom, Korea, Republic of
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
European Organisation for Research and Treatment...Danish Head and Neck Cancer GroupActive, not recruitingLocally Advanced Head and Neck HPV Negative Squamous Cell CancersBelgium, France, Poland, Australia, Germany, Netherlands, Switzerland
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell Lung | Solid Tumor | Pharmacokinetics | Triple Negative Breast NeoplasmsUnited States, Chile, Israel, Korea, Republic of, Netherlands, Spain, Taiwan
-
University Medical Center GroningenNot yet recruitingLocally Advanced Rectal CarcinomaNetherlands
-
The Netherlands Cancer InstituteRecruitingLocally Advanced, Squamous Cell Carcinoma of the VulvaNetherlands
-
University Hospital, AntwerpAgentschap voor Innovatie door Wetenschap en TechnologieCompletedLocally Advanced Squamous Cell Carcinoma of the Head and Neck RegionBelgium, Netherlands
-
The Netherlands Cancer InstituteCompletedInoperable Locally Advanced Non Small Cell Lung CancerNetherlands
-
Amsterdam UMC, location VUmcCompletedPancreatic Cancer | Locally Advanced Pancreatic Carcinoma (LAPC) | Non-metastasized Unresectable Pancreatic CarcinomaNetherlands
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Pancreatic Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Cancer | Esophageal Squamous Cell Cancer | BRAF Mutant Colorectal Cancer | Cervical Squamous Cell Cancer | Lung Squamous Cell CancerCanada, Italy, Spain, Germany, Netherlands, United States, France
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell CarcinomaUnited States, United Kingdom, Switzerland, Netherlands
-
The Netherlands Cancer InstituteRecruitingSquamous Cell Carcinoma of the Vulva | Locally Advanced Vulvar CarcinomaNetherlands
-
European Organisation for Research and Treatment...PfizerCompletedLocally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma | Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma | Locally Advanced... and other conditionsFrance, Belgium, Netherlands, Germany, United Kingdom, Italy, Norway, Poland, Slovakia, Slovenia
-
Novartis PharmaceuticalsTerminatedMelanoma | Head and Neck Cancer | Pancreatic Cancer | Urothelial Cancer | NSCLC, Non Small Cell Lung Cancer | RCC, Renal Cell Cancer | DLBCL, Diffused Large B Cell Lymphoma | MSS, Microsatellite Stable Colon Cancer | TNBC, Triple Negative Breast Cancer | mCRPC, Metastatic Castration Resistant Prostate...Belgium, Italy, Taiwan, Germany, Spain, United States, Argentina, Australia, Austria, Czechia, France, Japan, Netherlands, Switzerland, Singapore
-
Radboud University Medical CenterCompletedNSCLC | Locally Advanced Non-Small Cell Lung CancerNetherlands
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer FemaleUnited States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
-
Cytovation ASMerck Sharp & Dohme LLCActive, not recruitingAdvanced Breast Cancer | Advanced Melanoma | Advanced Head and Neck Squamous Cell CarcinomaUnited States, France, Italy, Spain, Netherlands
-
Leiden University Medical CenterErasmus Medical Center; HollandPTCRecruitingUterine Cervical Neoplasms | Locally Advanced Cervical CarcinomaNetherlands
-
Genentech, Inc.BioNTech SEActive, not recruitingMelanoma | Head and Neck Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | Renal Cancer | Other Solid CancersUnited States, Belgium, Sweden, Germany, Canada, Spain, United Kingdom, Netherlands
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
European Organisation for Research and Treatment...Merck KGaA, Darmstadt, GermanyRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaFrance, Belgium, Netherlands, Norway, United Kingdom, Ireland, Italy, Slovenia, Germany, Spain
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of
-
Academisch Medisch Centrum - Universiteit van Amsterdam...M.D. Anderson Cancer Center; University of Colorado, Denver; Radboud University... and other collaboratorsRecruitingPancreatic Cancer | Chemotherapy Effect | Locally Advanced Pancreatic Adenocarcinoma | Pancreatic Adenocarcinoma Non-resectableNetherlands
-
The Netherlands Cancer InstituteCatharina Ziekenhuis Eindhoven; ZonMw: The Netherlands Organisation for Health...RecruitingQuality of Life | Rectal Cancer | Organ Preservation | Locally Advanced Rectal CarcinomaNetherlands
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
IpsenActive, not recruitingLocally Advanced or Metastatic Renal Cell CarcinomaSpain, France, United Kingdom, Switzerland, Germany, Netherlands, Austria
-
Seagen Inc.RecruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Gastric Cancer | Ovarian Neoplasms | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Neoplasms | Esophageal Squamous Cell CarcinomaUnited States, Spain, Italy, Canada, United Kingdom, France, Belgium, Germany, Netherlands
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
Radboud University Medical CenterUnknownOvarian Cancer | Endometrial Cancer | Advanced/Recurrent Breast CancerNetherlands
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerKorea, Republic of, Italy, Poland, Malaysia, Taiwan, Thailand, United States, France, Netherlands, Philippines, Canada, Singapore, Spain, Turkey, Australia, Belgium, Israel